GAROFALO ELIZABETH A. exercised options at XENON PHARMACEUTICALS INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/4/2026ACC: 0001193125-26-256122
Director
Since Jun 2021
+12.10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
14.74K acquired · 2.65K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
+2.65K
Price / share
—
Trade value
—
% of position
New position
6/1/2026
0.00→2.65K
Total
Net shares
+2.65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/1/2026 | M · Option Exercise | +2.65K | — | — | New position | 0.00 | 2.65K |
| Total | +2.65K | $0.00 | ||||||
Derivative Transactions3
Restricted Share Units
Direct
Converts to
Common Shares
2.65K shares
Shares
−2.65K
Strike price
Held after
0.00
Exercisable
—
6/1/2026
Share Option (Right to Buy)
Direct
Converts to
Common Shares
10.51K shares
Shares
+10.51K
Strike price
53.46
Held after
10.51K
Exercisable
—
6/3/2026
Restricted Share Units
Direct
Converts to
Common Shares
1.59K shares
Shares
+1.59K
Strike price
0
Held after
1.59K
Exercisable
—
6/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Common Shares2.65K shares | 6/1/2026 | M · Option Exercise | −2.65K | — | 0.00 | |
| Share Option (Right to Buy) Direct | Common Shares10.51K shares | 6/3/2026 | A · Award | +10.51K | 53.46 | — | 10.51K |
| Restricted Share Units Direct | Common Shares1.59K shares | 6/3/2026 | A · Award | +1.59K | 0 | — | 1.59K |